HCL Centre Hospitalier Lyon Sud

Pierre-Bénite 69495

3 studies enrolling now · 10 studies all time

What they study most

Acute GVHD, Acute-graft-versus-host Disease, BK Virus Infection, Chronic Graft-versus-host-disease, Endometrial Cancer, Follicular Lymphoma, GVHD, Graft Versus Host Disease, Hemorrhagic Cystitis, Lymphoma, Diffuse Large B-Cell, Lymphoma, Non-Hodgkin's, Metastatic Breast Cancer

Studies at this site

• A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers — Recruiting now
• Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation — Recruiting now
• A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) — Recruiting now
• Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection — Recruiting now
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) — Running, not enrolling
• Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) — Running, not enrolling
• Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia — Running, not enrolling
• A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera — Running, not enrolling
• A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR) — Stopped early
• Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC) — Stopped early